RealMoney Silver
Special Message to RealMoney Silver Subscribers:
"No one else knows ETFs like Don Dion!" - Jim Cramer
ETF Action by Don Dion is TheStreet's newest service. Try it free today!
Go
Home | TheStreet Picks | RealMoney | RealMoney Ideas | Earnings Calls | Analyst Upgrades/Downgrades | Columnist Conversation | RealMoney TV (NEW) | Bios | Getting Started
Help | Advanced Search | Logoff

TheStreet Picks
Action Alerts PLUS
By Jim Cramer
Portfolio  |  Archives  |  Author's Bio
GILD
New Licensing Venture Is a Plus for a Drug Holding
This remains an HIV story, but new exposure to hep B in Asia will help the company. MoreMore

EMR
Good Showing on Orders
Don't attribute all the positives in this holding's book to a weaker dollar. MoreMore

WFT
Adding to an Oil-Service Play
The company still has upside, and its stock is down on a lowered earnings estimate. MoreMore


TheStreet.com Options Alerts
By Jud Pyle CFA
Portfolio  |  Archives  |  Author's Bio
MWW WFT AMED
Playing the Limits
Our strategy for this market of limited downside and upside is to continue to buy call spreads and sell put spreads. MoreMore

POT SCHW AMED
Preparing for Options Expiration
As this is also the week before Thanksgiving, many market players will likely be looking to square their positions. MoreMore

POT
Making an Exit
With options expiration coming up next week, it's time to close a portion of this model portfolio position. MoreMore


TheStreet.com Stocks Under $10
By The Stocks Under $10 Investment Team
Portfolio  |  Archives  |  Author's Bio
VVUS WEN
A Pair of Updates
Two model portfolio names are in the news today amid chatter on an obesity-drug study and a takeout rumor. MoreMore

ARTG AUY COT
Stocks Under $10 Weekly Summary
We put some cash to work this week as the model portfolio's benchmark, the Russell 2000, fell for four straight days. MoreMore

TQNT
Buying on Weakness
Adding to our position and upgrading our rating as we believe the company will rebound in the current period. MoreMore

RealMoney Investment & Trading Ideas

Doug Kass
Case-Shiller Is a Downer
Prospects for a sustained increase in home prices...  MoreMore


Jim Cramer
Oil Futures Are Still the Key to Stocks
If oil can't hold $75, then you can buy some good names on sale. MoreMore


Rev Shark
Looking for Downside
Seasonality is no match for a weak China. MoreMore


Don Dion
Chinese IPO Could Shake Up Wind ETFs
These funds, however, are subject to wild swings on low volume. MoreMore


Jay Somaney
H-P Posts a Solid Quarter
Results were roughly in line with expectations, and nothing in the call should change your thinking on the company. MoreMore


Dan Fitzpatrick
Fitz Bits: Two Ways to Look at United Tech
What you do next depends on whether you're long or looking to get long. MoreMore


Adam Feuerstein
Cel-Sci's History of Disappearing Drugs: BioBuzz
Will the company's flu drug last longer than its other fly-by-night projects? MoreMore


Jim Cramer
Ciena's Move Is a Winner
The quick negative judgment on the Nortel deal is flatly wrong. MoreMore


Ben Thomas
Brocade Beats, but Rumors Remain
The just-posted quarter makes the tech play an attractive takeover candidate, and a speculative position may be warranted. MoreMore


Howard Simons
Reading the Bump in Lumber Prices
It could bode well for homebuilders, or it may just be a tease. MoreMore


Rev Shark
Supply and Demand
As long as the dollar stays weak and liquidity is abundant, we can move higher despite low volume. MoreMore


Helene Meisler
Lousy Statistics Are Hard to Spin
The market's not oversold enough for me to think it can keep rising on these weak numbers. MoreMore


Marco Hague
Late Buyers Propel Europe Higher
Financials have been a drag today, but global markets are again in the green heading into the U.S. session. MoreMore


Don Dion
A Showdown in Coal ETFs
Two ETFs aim to track the production, transportation and storage of coal. MoreMore


Adam Feuerstein
BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims. MoreMore


Jim Cramer
The Fed's Push for TARP Payback
The sooner banks repay TARP, the more likely they will power higher in 2010. MoreMore


Marco Hague
U.S. Rates: On the Low End of High
The economy is recovering, and interest rates can't go any lower. MoreMore


Bob Faulkner
ADI Summary: Blowing Through Estimates
Results were well above consensus, and guidance sends a positive message. MoreMore


Marco Hague
Global Market Wrap
Each of the nine sectors in the U.S. market advanced in Monday's up-then-down trading. MoreMore


Jim Cramer
AT&T and Verizon Send Positive Signals
These two misunderstood stocks are actually plays on an economic recovery. MoreMore


Don Dion
China ETFs Slip on Fears of a Bubble
However, relative momentum in these funds has improved. MoreMore


More RealMoney Investment & Trading IdeasMore

Columnist Conversation
Howard Simons
Political Pseudo-Correlation Analysis
Bloomberg is running a story comparing Obama's popularity rating against the dollar. This week's... MoreMore

Howard Simons
Market Valuation
Brian, I've been using the yield on the Merrill Lynch Corporate Master index as the comparative... MoreMore

Timothy Collins
Some bull riding action in smallcap ags
Over the last two days, a group of us have been following Origin Agritech Limited (SEED), AgFeed... MoreMore


More Columnist ConversationMore


Earnings Calls
This Week's Earnings Calls

American Eagle Outfitters Preview

Analog Devices Summary

Hewlett-Packard Summary

Brocade Communications Systems Summary


More Earnings CallsMore


Analyst Upgrades/Downgrades
Eastman Chemical upgraded at Deutsche
8:41 AM EST

Lexicon Pharmaceuticals initiated at Thomas Weisel
8:30 AM EST

St. Jude Medical rated new Buy at Morgan Joseph
8:28 AM EST


More Upgrades/DowngradesMore



Terms of Use | Privacy Policy

© 1996- TheStreet.com, Inc. All rights reserved.